Titre : Gomme adragante

Gomme adragante : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet Transfusion
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Gomme adragante : Questions médicales les plus fréquentes", "headline": "Gomme adragante : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Gomme adragante : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-07", "dateModified": "2025-03-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Gomme adragante" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Gommes végétales", "url": "https://questionsmedicales.fr/mesh/D053149", "about": { "@type": "MedicalCondition", "name": "Gommes végétales", "code": { "@type": "MedicalCode", "code": "D053149", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D20.215.721.249" } } }, "about": { "@type": "MedicalCondition", "name": "Gomme adragante", "alternateName": "Tragacanth", "code": { "@type": "MedicalCode", "code": "D014144", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hajar Shekarchizadeh", "url": "https://questionsmedicales.fr/author/Hajar%20Shekarchizadeh", "affiliation": { "@type": "Organization", "name": "Department of Food Science and Technology, College of Agriculture, Isfahan University of Technology, Isfahan 84156-83111, Iran. Electronic address: Shekarchizadeh@iut.ac.ir." } }, { "@type": "Person", "name": "Shadpour Mallakpour", "url": "https://questionsmedicales.fr/author/Shadpour%20Mallakpour", "affiliation": { "@type": "Organization", "name": "Organic Polymer Chemistry Research Laboratory, Department of Chemistry, Isfahan University of Technology, Isfahan 84156-83111, Islamic Republic of Iran. Electronic address: mallak@iut.ac.ir." } }, { "@type": "Person", "name": "Jaleh Varshosaz", "url": "https://questionsmedicales.fr/author/Jaleh%20Varshosaz", "affiliation": { "@type": "Organization", "name": "Department of Pharmaceutics, Faculty of Pharmacy and Novel Drug Delivery Systems, Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: varshosaz@pharm.mui.ac.ir." } }, { "@type": "Person", "name": "Majid Montazer", "url": "https://questionsmedicales.fr/author/Majid%20Montazer", "affiliation": { "@type": "Organization", "name": "Textile Engineering Department, Functional Fibrous Structures & Environmental Enhancement (FFSEE), Amirkabir University of Technology, Tehran, Iran. Electronic address: tex5mm@aut.ac.ir." } }, { "@type": "Person", "name": "Mohammad Sadegh Nourbakhsh", "url": "https://questionsmedicales.fr/author/Mohammad%20Sadegh%20Nourbakhsh", "affiliation": { "@type": "Organization", "name": "Faculty of New Sciences and Technologies, Semnan University, P.O. Box 19111-35131, Semnan, Iran; Faculty of Materials and Metallurgical Engineering, Semnan University, P.O. Box 19111-35131, Semnan, Iran. Electronic address: s_nourbakhsh@semnan.ac.ir." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36599813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ejh.13925" } }, { "@type": "ScholarlyArticle", "name": "Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.", "datePublished": "2022-12-01", "url": "https://questionsmedicales.fr/article/36454598", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/vox.13387" } }, { "@type": "ScholarlyArticle", "name": "The safety of ABO minor incompatible platelets transfusions using a rapid infuser.", "datePublished": "2024-02-01", "url": "https://questionsmedicales.fr/article/38299721", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/trf.17739" } }, { "@type": "ScholarlyArticle", "name": "Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.", "datePublished": "2023-02-09", "url": "https://questionsmedicales.fr/article/36758527", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000529542" } }, { "@type": "ScholarlyArticle", "name": "Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.", "datePublished": "2022-11-12", "url": "https://questionsmedicales.fr/article/36369934", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/trf.17184" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Mélanges complexes", "item": "https://questionsmedicales.fr/mesh/D045424" }, { "@type": "ListItem", "position": 3, "name": "Produits biologiques", "item": "https://questionsmedicales.fr/mesh/D001688" }, { "@type": "ListItem", "position": 4, "name": "Exsudats végétaux", "item": "https://questionsmedicales.fr/mesh/D053147" }, { "@type": "ListItem", "position": 5, "name": "Gommes végétales", "item": "https://questionsmedicales.fr/mesh/D053149" }, { "@type": "ListItem", "position": 6, "name": "Gomme adragante", "item": "https://questionsmedicales.fr/mesh/D014144" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Gomme adragante - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Gomme adragante", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Gomme adragante", "description": "Comment diagnostiquer une allergie à la gomme adragante ?\nQuels symptômes indiquent une réaction à la gomme adragante ?\nQuels tests sont utilisés pour évaluer l'usage de la gomme adragante ?\nLa gomme adragante peut-elle interférer avec d'autres médicaments ?\nComment évaluer la qualité de la gomme adragante ?", "url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Platelet+Transfusion&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Gomme adragante", "description": "Quels sont les symptômes d'une ingestion excessive de gomme adragante ?\nLa gomme adragante peut-elle causer des troubles digestifs ?\nQuels signes indiquent une hypersensibilité à la gomme adragante ?\nLa gomme adragante peut-elle provoquer des effets secondaires ?\nQuels symptômes sont associés à une allergie à la gomme adragante ?", "url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Platelet+Transfusion&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Gomme adragante", "description": "Comment éviter une réaction allergique à la gomme adragante ?\nQuelles précautions prendre lors de l'utilisation de la gomme adragante ?\nLa gomme adragante est-elle sûre pour les enfants ?\nComment informer les patients sur la gomme adragante ?\nQuels conseils donner pour une utilisation sécurisée de la gomme adragante ?", "url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Platelet+Transfusion&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Gomme adragante", "description": "Comment traiter une allergie à la gomme adragante ?\nQuels remèdes naturels peuvent apaiser les effets de la gomme adragante ?\nLa gomme adragante est-elle utilisée en médecine traditionnelle ?\nQuels traitements sont disponibles pour les troubles digestifs causés par la gomme ?\nComment gérer les effets indésirables de la gomme adragante ?", "url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Platelet+Transfusion&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Gomme adragante", "description": "Quelles complications peuvent survenir avec la gomme adragante ?\nLa gomme adragante peut-elle causer des obstructions intestinales ?\nQuels sont les risques d'une utilisation prolongée de la gomme adragante ?\nComment gérer les complications liées à la gomme adragante ?\nLes complications de la gomme adragante sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Platelet+Transfusion&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Gomme adragante", "description": "Qui est à risque d'allergie à la gomme adragante ?\nLes personnes asthmatiques sont-elles plus sensibles à la gomme adragante ?\nQuels aliments peuvent contenir de la gomme adragante ?\nLes femmes enceintes doivent-elles éviter la gomme adragante ?\nQuels facteurs augmentent le risque de complications avec la gomme adragante ?", "url": "https://questionsmedicales.fr/mesh/D014144?mesh_terms=Platelet+Transfusion&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une allergie à la gomme adragante ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané ou un test sanguin peut être effectué pour confirmer l'allergie." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réaction à la gomme adragante ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des démangeaisons, éruptions cutanées ou difficultés respiratoires peuvent survenir." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'usage de la gomme adragante ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de tolérance alimentaire peuvent être réalisés pour évaluer son utilisation." } }, { "@type": "Question", "name": "La gomme adragante peut-elle interférer avec d'autres médicaments ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut affecter l'absorption de certains médicaments, nécessitant une évaluation." } }, { "@type": "Question", "name": "Comment évaluer la qualité de la gomme adragante ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de pureté et d'analyses chimiques sont effectués pour évaluer sa qualité." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une ingestion excessive de gomme adragante ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales, des nausées et des vomissements peuvent se manifester." } }, { "@type": "Question", "name": "La gomme adragante peut-elle causer des troubles digestifs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut provoquer des ballonnements ou des troubles intestinaux chez certaines personnes." } }, { "@type": "Question", "name": "Quels signes indiquent une hypersensibilité à la gomme adragante ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, des démangeaisons ou un gonflement peuvent indiquer une hypersensibilité." } }, { "@type": "Question", "name": "La gomme adragante peut-elle provoquer des effets secondaires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des troubles gastro-intestinaux peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes sont associés à une allergie à la gomme adragante ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des démangeaisons, des éruptions cutanées et des difficultés respiratoires." } }, { "@type": "Question", "name": "Comment éviter une réaction allergique à la gomme adragante ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits contenant de la gomme adragante si vous êtes allergique." } }, { "@type": "Question", "name": "Quelles précautions prendre lors de l'utilisation de la gomme adragante ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Lisez les étiquettes des produits et consultez un professionnel de santé si nécessaire." } }, { "@type": "Question", "name": "La gomme adragante est-elle sûre pour les enfants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être utilisée, mais il est préférable de consulter un pédiatre avant utilisation." } }, { "@type": "Question", "name": "Comment informer les patients sur la gomme adragante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Fournissez des informations sur ses usages, effets secondaires et alternatives possibles." } }, { "@type": "Question", "name": "Quels conseils donner pour une utilisation sécurisée de la gomme adragante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez-la en quantités recommandées et surveillez les réactions indésirables." } }, { "@type": "Question", "name": "Comment traiter une allergie à la gomme adragante ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "L'évitement de la gomme adragante et des antihistaminiques peuvent être recommandés." } }, { "@type": "Question", "name": "Quels remèdes naturels peuvent apaiser les effets de la gomme adragante ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des infusions de camomille ou de menthe peuvent aider à soulager les troubles digestifs." } }, { "@type": "Question", "name": "La gomme adragante est-elle utilisée en médecine traditionnelle ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée comme émollient et laxatif dans certaines médecines traditionnelles." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles digestifs causés par la gomme ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antiacides ou des probiotiques peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Comment gérer les effets indésirables de la gomme adragante ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de consulter un médecin pour ajuster le traitement ou changer de produit." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la gomme adragante ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques graves ou des troubles digestifs peuvent survenir." } }, { "@type": "Question", "name": "La gomme adragante peut-elle causer des obstructions intestinales ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Dans de rares cas, une ingestion excessive peut entraîner des obstructions intestinales." } }, { "@type": "Question", "name": "Quels sont les risques d'une utilisation prolongée de la gomme adragante ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une utilisation prolongée peut entraîner des déséquilibres électrolytiques ou des troubles digestifs." } }, { "@type": "Question", "name": "Comment gérer les complications liées à la gomme adragante ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un professionnel de santé pour évaluer et traiter les complications éventuelles." } }, { "@type": "Question", "name": "Les complications de la gomme adragante sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout en cas d'allergie." } }, { "@type": "Question", "name": "Qui est à risque d'allergie à la gomme adragante ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies alimentaires sont plus à risque." } }, { "@type": "Question", "name": "Les personnes asthmatiques sont-elles plus sensibles à la gomme adragante ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes asthmatiques peuvent être plus sensibles aux allergènes, y compris la gomme." } }, { "@type": "Question", "name": "Quels aliments peuvent contenir de la gomme adragante ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Elle est souvent présente dans les bonbons, les sauces et certains produits laitiers." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles éviter la gomme adragante ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de consulter un médecin avant d'utiliser la gomme adragante pendant la grossesse." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications avec la gomme adragante ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation excessive ou des allergies préexistantes augmentent le risque de complications." } } ] } ] }

Sources (7092 au total)

Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.

Platelet transfusions are used across multiple patient populations to prevent and correct bleeding. This scoping review aimed to map the currently available systematic reviews (SRs) and evidence-based... A systematic literature search was conducted in seven databases for SRs on effectiveness (including dose and timing, transfusion trigger and ratio to other blood products), production modalities and d... We identified 110 SRs. The majority focused on clinical effectiveness, including prophylactic or therapeutic transfusions compared to no platelet transfusion (34 SRs), prophylactic compared to therape... An interactive evidence map of SRs and evidence-based guidelines in the field of platelet transfusion has been developed and identified multiple reviews. This work serves as a tool for researchers loo...

The safety of ABO minor incompatible platelets transfusions using a rapid infuser.

Administering platelets through a rapid infuser is proven to be safe. However, the clinical significance of infusing ABO-incompatible platelets with red blood cells (RBCs) in a rapid infuser remains u... Seven in vitro studies were performed including five cases (type A RBCs and type O platelets) and two controls (type A RBCs and platelets). Anti-A titers were measured in platelet units. An RBC unit a... The post-mix DAT was positive for IgG in all test samples (5/5), and weakly positive for complement in 3/5. The changes in free Hb in test cases between measured and calculated post-mix spanned -2.2 t... Our study suggested that mixing ABO-incompatible platelets with RBCs in a rapid infuser does not induce in vitro hemolysis. These findings support the use of rapid infusers regardless of platelet comp...

Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.

The aims of this study were to observe the therapeutic effect of platelet (PLT) transfusion and to analyze influencing factors for the sake of providing useful clues for improving the efficacy of PLT ... Included in this study were patients who received PLT transfusion in the affiliated hospital of Nantong University. Patients' sex, age, height, weight, PLT transfusion status, and 20-24-h PLT count be... A total of 364 patients received 1,060 PLT transfusions, including 728 successful transfusions and 332 unsuccessful transfusions. When the patients were grouped according to different etiologies, sign... To reduce PTR, multiple factors should be considered comprehensively when PLT transfusion therapy is to be implemented in clinical practice. PLT antibody is the main immune factor causing PTR....

Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.

Following the results of the PlaNeT-2 randomized controlled trial showing decreased morbidity and mortality in neonates transfused at a threshold of 25 versus 50 × 10... Prospective observational cohort chart-review study comparing all neonates consecutively admitted to the NICU during two 5-months periods: 2013 (before; N = 401) versus 2021 (after; N = 402). Possible... Mean (± standard deviation) gestational age and birth weight were 34.9 ± 4.2 weeks and 2.5 ± 1.0 kg, respectively. In 2021, 5.0% were platelet-transfused versus 9.2% in 2013 (p = .027). Platelet trans... Restrictive local transfusion thresholds in a NICU decreased the proportion of platelet-transfused neonates by 46% and reduced donor exposure in transfused patients....

Two-year outcomes following a randomised platelet transfusion trial in preterm infants.

Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia... Randomised clinical trial, enrolling from June 2011 to August 2017. Follow-up was complete by January 2020. Caregivers were not blinded; however, outcome assessors were blinded to treatment group.... 43 level II/III/IV neonatal intensive care units (NICUs) across UK, Netherlands and Ireland.... 660 infants born at less than 34 weeks' gestation with platelet counts less than 50×10... Infants were randomised to undergo a platelet transfusion at platelet count thresholds of 50×10... Our prespecified long-term follow-up outcome was a composite of death or neurodevelopmental impairment (developmental delay, cerebral palsy, seizure disorder, profound hearing or vision loss) at 2 yea... Follow-up data were available for 601 of 653 (92%) eligible participants. Of the 296 infants assigned to the higher threshold group, 147 (50%) died or survived with neurodevelopmental impairment, as c... Infants randomised to a higher platelet transfusion threshold of 50×10... ISRCTN87736839....

Aged versus fresh autologous platelet transfusion in a two-hit healthy volunteer model of transfusion-related acute lung injury.

Transfusion-related acute lung injury (TRALI) is a severe complication of blood transfusion that is thought of as a two-hit event: first the underlying patient condition (e.g., sepsis), and then the t... In a randomized controlled trial, 18 healthy male volunteers received a first hit of experimental endotoxemia (2 ng/kg lipopolysaccharide), and a second hit of fresh (2-day old) or aged (7-day old) au... All subjects reacted adequately to lipopolysaccharide infusion and satisfied SIRS criteria (increased pulse [>90/min] and temperature [>38°C]). There were no differences between the saline, fresh, and... In a human endotoxemia model of autologous platelet transfusion, with an adequate first hit and platelet storage lesion, transfusion of 7-day-old PC does not increase pulmonary inflammation compared w...

A randomized cross-over study of cryopreserved platelets in prophylactic transfusions of thrombocytopenic patients.

The short shelf-life of liquid-stored platelets (LP) at 20-24°C poses shortage and wastage challenges. Cryopreserved platelets have significantly extended shelf-life, and were safe and efficacious for... We performed a phase 1b/2a randomized cross-over study comparing the safety and efficacy of cryopreserved buffy coat-derived pooled platelets (CP) to LP in the prophylactic transfusions of thrombocyto... A total of 18 adults were randomly assigned 1:1 to CP and LP for their first thrombocytopenic period (TP) of up to 28-days. A total of 14 crossed over to the other platelet-arm for the second TP. Over... During shortages, CP may supplement LP in prophylactic transfusions of thrombocytopenic patients....